Houston, TX, United States of America

Yannick Bulliard

USPTO Granted Patents = 6 

Average Co-Inventor Count = 5.3

ph-index = 1


Location History:

  • Houston, TX (US) (2023)
  • Thousand Oaks, CA (US) (2023 - 2024)
  • Sugar Land, TX (US) (2024)

Company Filing History:


Years Active: 2023-2025

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Yannick Bulliard: Pioneering Innovator in Cellular Therapy Technologies

Introduction: Yannick Bulliard, a distinguished inventor based in Houston, TX, is making waves in the field of adoptive cellular therapy with his groundbreaking patents. Holding a total of 3 patents, Bulliard's work at Immatics US, Inc. is at the forefront of cutting-edge medical advancements.

Latest Patents:

1. Viral vectors and use thereof in adoptive cellular therapy: This patent encompasses a vector containing distinct nucleotide sequences encoding proteins that play a vital role in cellular therapy. The unique arrangement of protein dimers demonstrates Bulliard's innovative approach to enhancing therapeutic outcomes.

2. WPRE mutant constructs, compositions, and methods thereof: Bulliard's mutated woodchuck post-transcriptional regulatory element (WPRE) patent focuses on optimizing the expression of nucleotides in a retroviral vector system. This innovation holds promise for more efficient delivery and expression of target nucleotides in cellular environments.

Career Highlights: Yannick Bulliard's career trajectory showcases his dedication to transformative medical technologies. His tenure at Immatics US, Inc. has been marked by a series of impactful inventions that are shaping the future of cellular therapy. Bulliard's expertise lies in harnessing viral vectors for therapeutic applications, revolutionizing treatment strategies for various diseases.

Collaborations: Within Immatics US, Inc., Bulliard collaborates closely with esteemed colleagues such as Steffen Walter and Melinda Mata. Together, they form a formidable team driving innovation and pushing the boundaries of adoptive cellular therapy.

Conclusion: In conclusion, Yannick Bulliard's inventive spirit and remarkable contributions to the field of cellular therapy position him as a trailblazing figure in medical innovation. His patents reflect a commitment to improving patient outcomes and advancing the frontiers of science. As Bulliard continues to pioneer new technologies, the future of adoptive cellular therapy looks brighter than ever.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…